Literature DB >> 7479971

Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.

S P Schwendeman1, H R Costantino, R K Gupta, G R Siber, A M Klibanov, R Langer.   

Abstract

The progress toward single-dose vaccines has been limited by the poor solid-state stability of vaccine antigens within controlled-release polymers, such as poly(lactide-co-glycolide). For example, herein we report that lyophilized tetanus toxoid aggregates during incubation at 37 degrees C and elevated humidity--i.e., conditions relevant to its release from such systems. The mechanism and extent of this aggregation are dependent on the moisture level in the solid protein, with maximum aggregation observed at intermediate moisture contents. The main aggregation pathway is consistent with formaldehyde-mediated cross-linking, where reactive electrophiles created and stored in the vaccine upon formalinization (exposure to formaldehyde during vaccine preparation) react with nucleophiles of a second vaccine molecule to form intermolecular cross-links. This process is inhibited by the following: (i) succinylating the vaccine to block reactive amino groups; (ii) treating the vaccine with sodium cyanoborohydride, which presumably reduces Schiff bases and some other electrophiles created upon formalinization; and (iii) addition of low-molecular-weight excipients, particularly sorbitol. The moisture-induced aggregation of another formalinized vaccine, diphtheria toxoid, is also retarded by succinylation, suggesting the generality of this mechanism for formalinized vaccines. Hence, mechanistic stability studies of the type described herein may be important for the development of effective single-dose vaccines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479971      PMCID: PMC40606          DOI: 10.1073/pnas.92.24.11234

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Parameters affecting the immunogenicity of microencapsulated tetanus toxoid.

Authors:  I Esparza; T Kissel
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

Authors:  A F Habeeb
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

3.  Radioactive labeling of proteins in vitro.

Authors:  R H Rice; G E Means
Journal:  J Biol Chem       Date:  1971-02-10       Impact factor: 5.157

4.  Radiolabeling of proteins by reductive alkylation with [14C]formaldehyde and sodium cyanoborohydride.

Authors:  D Dottavio-Martin; J M Ravel
Journal:  Anal Biochem       Date:  1978-07-01       Impact factor: 3.365

5.  Lyophilization-induced reversible changes in the secondary structure of proteins.

Authors:  K Griebenow; A M Klibanov
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  Reassessment of Ellman's reagent.

Authors:  P W Riddles; R L Blakeley; B Zerner
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

Authors:  M J Alonso; R K Gupta; C Min; G R Siber; R Langer
Journal:  Vaccine       Date:  1994-03       Impact factor: 3.641

Review 8.  Adjuvants for human vaccines--current status, problems and future prospects.

Authors:  R K Gupta; G R Siber
Journal:  Vaccine       Date:  1995-10       Impact factor: 3.641

9.  Moisture-induced aggregation of lyophilized proteins in the solid state.

Authors:  W R Liu; R Langer; A M Klibanov
Journal:  Biotechnol Bioeng       Date:  1991-01-20       Impact factor: 4.530

10.  Moisture-induced aggregation of lyophilized insulin.

Authors:  H R Costantino; R Langer; A M Klibanov
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

View more
  20 in total

1.  Accelerated stability studies for moisture-induced aggregation of tetanus toxoid.

Authors:  Nishant Kumar Jain; Ipsita Roy
Journal:  Pharm Res       Date:  2010-11-12       Impact factor: 4.200

2.  Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

Authors:  P Johansen; Y Men; R Audran; G Corradin; H P Merkle; B Gander
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  Nucleic acid aptamers as stabilizers of proteins: the stability of tetanus toxoid.

Authors:  Nishant Kumar Jain; Hardik C Jetani; Ipsita Roy
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

4.  Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives.

Authors:  G Zhu; S P Schwendeman
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

5.  Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice.

Authors:  D Pavliakova; C Chu; S Bystricky; N W Tolson; J Shiloach; J B Kaufman; D A Bryla; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 6.  Effect of trehalose on protein structure.

Authors:  Nishant Kumar Jain; Ipsita Roy
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

7.  Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.

Authors:  R Audran; Y Men; P Johansen; B Gander; G Corradin
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

8.  Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.

Authors:  Ying Zhang; Andreas M Sophocleous; Steven P Schwendeman
Journal:  Pharm Res       Date:  2009-06-16       Impact factor: 4.200

9.  Absolute Humidity Influences the Seasonal Persistence and Infectivity of Human Norovirus.

Authors:  Alexandre Colas de la Noue; Marie Estienney; Serge Aho; Jean-Marie Perrier-Cornet; Alexis de Rougemont; Pierre Pothier; Patrick Gervais; Gaël Belliot
Journal:  Appl Environ Microbiol       Date:  2014-09-12       Impact factor: 4.792

Review 10.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.